AU Stock MarketDetailed Quotes

AVE Avecho Biotechnology Ltd

Watchlist
  • 0.005
  • 0.0000.00%
20min DelayMarket Closed Mar 31 16:00 AET
15.85MMarket Cap-5.00P/E (Static)

About Avecho Biotechnology Ltd Company

Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.

Company Profile

SymbolAVE
Company NameAvecho Biotechnology Ltd
Founded1992
MarketASX
Employees34
Fiscal Year Ends12-31
AddressUnit A8, 2A Westall Road Clayton
CityMelbourne
CountryAustralia
Zip Code3168
Phone+61 390025000
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED Yarra Falls, 452 Johnston Street, ABBOTSFORD, VIC, AUSTRALIA, 3067 03 9415 4000

Company Executives

  • Name
  • Position
  • Salary
  • Gregory (Greg) Collier
  • Non-Executive Chairman,Non-Executive Director
  • --
  • Ross Murdoch
  • Non-Executive Director
  • --
  • Matthew Patrick McNamara
  • Non-Executive Director
  • --

Market Insights

Discussing
北水爆買!中國資產能否延續漲勢?
3月17日早盤,地產代理、物業服務及管理等板塊漲幅明顯,貝殼-W早盤漲逾4%,碧桂園服務漲逾9%。政策消息面上,兩部門發文落實專項債支持收地,中房協組織民營房企座談會。中國資產本輪火爆行情還能持續多久?你會如何投資? Show More